Company Overview
Neogen Chemicals Limited, a leading specialty chemicals company, held its 37th Annual General Meeting on August 21, 2026, presenting comprehensive financial results and strategic updates for FY 2025-26.
Financial Performance
Standalone Results: Revenue grew 11% to ₹855.5 crore in FY26 from ₹773.7 crore in FY25, driven by improved volumes and new customer additions. However, net profit declined 3% to ₹47 crore from ₹48.4 crore due to battery materials ramp-up costs and higher finance expenses. EBITDA margin compressed to 17.7% from 19.0%.
Consolidated Performance: Revenue reached ₹862 crore (+11% YoY) with EBITDA of ₹137 crore and PAT of ₹29 crore. Key financial ratios showed deterioration with debt-equity ratio increasing to 0.79x from 0.55x and interest coverage ratio declining to 1.78x from 2.56x.
Strategic Developments
Battery Materials Expansion: The company is executing a ₹1,795 crore integrated battery materials project through subsidiary Neogen Ionics Limited at Pakhajan, Gujarat, with planned capacity of 30,000 MT electrolytes and 3,000 MT lithium electrolyte salts. The joint venture with Morita Chemicals (20% stake for $20 million) focuses on lithium hexafluorophosphate production. Commercial production is expected in H1 FY27 for electrolytes and H2 FY27 for electrolyte salts.
Dahej Fire Recovery: The March 2025 fire incident caused ₹348 crore in losses, with ₹140 crore received as on-account insurance payments and ₹7 crore from scrap sales. The outstanding insurance claim stands at ₹189 crore as of March 31, 2026, with facility rebuilding expected completion in H1 FY27.
Capital Raising Activities
Preferential Issue: The company completed a ₹161 crore preferential share issue to promoter group entity Cadamba Solutions at ₹1,610 per share (17% premium to SEBI floor price) in April 2026.
QIP Proposal: Shareholders approved raising up to ₹600 crore through Qualified Institutions Placement for business expansion, capex, working capital, debt repayment, and subsidiary investments, with general corporate purposes capped at 25%.
Debt Structure: Total borrowings stood at ₹671 crore (standalone) and ₹1,330 crore (consolidated), including ₹200 crore raised through Non-Convertible Debentures at 10.5% interest.
Corporate Governance & Compliance
Board Changes: Haridas Kanani retired as Chairman and MD, transitioning to Chairman Emeritus, while Anurag Surana was appointed as Non-Executive Chairman. The company faced SEBI penalties of ₹10.62 lakh for non-compliance with director appointment regulations.
Dividend: The board recommended a final dividend of ₹1 per equity share (10% of face value) for FY26, subject to shareholder approval.
MSME & Supplier Finance: The company disclosed ₹20.23 crore in unpaid MSME dues with ₹1.09 crore interest accrued, and ₹234.71 crore of trade payables covered under supplier finance arrangements.
Operational Highlights
Capacity Expansion: Patancheru plant capacity expanded from 120 MT to 300 MT for organolithium products. The company maintains 7 manufacturing facilities, 2 R&D centers, and exports to 36 countries with 29% export contribution.
ESOP Scheme: Granted 86,600 stock options to employees under the 2024 ESOP scheme, with ₹0.87 crore recognized as expense.
Outlook
The company provided standalone revenue guidance of ₹875-950 crore for FY27, with commissioning of Dahej replacement plant and Pakhajan battery materials facility expected in H1 and H2 FY27 respectively. The battery materials segment is positioned as a significant growth driver amid positive medium-term outlook for specialty chemicals demand.